title: Effect of polymer molecular weight and of polymer blends on the properties of rapidly gelling nasal inserts.
abstract: The objective was to investigate the potential of polymer molecular weight (MW) and polymer blends for the control of drug release from in situ gelling nasal inserts prepared by lyophilization of solutions of model drugs (oxymetazoline HCl, diprophyllin) and polymers. Drug release, polymer solution viscosity, water uptake and mass loss, mechanical properties, and bioadhesion potential were measured. Sonication was effective to reduce the viscosity/polymer MW of carrageenan solutions. Nasal inserts prepared from sonicated carrageenan showed an insignificant reduction in water uptake with sonication time and no disintegration of the gel matrix. In contrast, inserts of different MW Na-alginates revealed a reduced water uptake and an increased mass loss with lower MW. Inserts prepared from carrageenan/low MW Na-alginate blends took up more water at a higher low MW Na-alginate content. Sonicated carrageenan inserts released oxymetazoline HCl independent of the sonication time and diprophyllin with only a slight reduction in the release rate. Release of both drugs from Na-alginate inserts was slow from high MW inserts because no insert dissolution occurred. Increasing the Na-alginate content of inserts prepared from polymer blends accelerated the drug release enabling release rates over a broad range. The bioadhesion potential of Na-alginate inserts was strongly reduced for the low MW grades because of dissolution of the inserts. Xanthan gum and Carbopol 971 blended with Na-alginate formed inserts with poor bioadhesion. The use of polymer blends to control the drug release from nasal inserts was superior to the use of polymers of different MW.
authors.affiliation: College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Bertram
authors.forename: Roland
authors.initials: R
authors.lastname: Bodmeier
mesh_terms: D000281:Administration, Intranasal / Q000379:methods; D000464:Alginates / Q000737:chemistry* / Q000378:metabolism; D002351:Carrageenan / Q000737:chemistry* / Q000378:metabolism; D003692:Delayed-Action Preparations / Q000737:chemistry / Q000378:metabolism; D016503:Drug Delivery Systems; D005782:Gels / Q000737:chemistry*; D008970:Molecular Weight; D009296:Nasal Cavity / Q000378:metabolism*; D009297:Nasal Mucosa / Q000378:metabolism*; D011108:Polymers / Q000737:chemistry*; D013499:Surface Properties
chemical_list: D000464:Alginates; D003692:Delayed-Action Preparations; D005782:Gels; D011108:Polymers; D002351:Carrageenan